Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Dr. Leslie Alexandre to Leave N.C. Biotechnology Center

    RESEARCH TRIANGLE PARK, N.C., Jan. 22 /PRNewswire/ -- The North
Carolina Biotechnology Center today announced that President and CEO Leslie
Alexandre, Dr. P.H., has resigned to pursue new opportunities. To
facilitate a smooth transition, Dr. Alexandre will continue working with
the Biotechnology Center as needed until March 31.
    "Leslie Alexandre has led the Biotechnology Center through a notable
period of growth," said Sue Cole, chairman of the Biotechnology Center's
board of directors. "She has helped enhance North Carolina's reputation as
a 'biotech-friendly' state. Citizens will benefit in the coming years from
the groundwork she has laid."
    "Leading the Biotechnology Center since 2002 has been exciting and
rewarding," said Dr. Alexandre. "I leave having accomplished what I set out
to do when I arrived: strengthen the Biotechnology Center's programs,
services and infrastructure and expand its reach to all corners of the
state through the establishment of regional offices; secure greater State
funding to support additional innovative research projects and company
startups; increase life science company expansions and attractions by
building high-impact partnerships with the N.C. Department of Commerce and
other economic developers; and broaden global recognition of North Carolina
as a leading place to conduct biotechnology research, development and
commercialization."
    Dr. Alexandre also led the creation of New Jobs Across North Carolina:
a Strategic Plan for Growing the Economy Statewide through Biotechnology on
behalf of Governor Mike Easley. "Our strategic plan has already had a very
positive impact on our state, and I believe that its continued
implementation will ensure a bright future for North Carolina
biotechnology," she said. "The Biotechnology Center is well positioned to
lead that future for years to come.
    "I will miss my wonderful staff and the energy of the Biotechnology
Center, but I will watch with pride as they continue to accomplish great
things for the people of North Carolina," concluded Dr. Alexandre.
    The Board of Directors of the Biotechnology Center will conduct a
national search for the President and CEO position.
    The Biotechnology Center, headquartered in Research Triangle Park with
five regional offices throughout the state, is a private, non-profit
corporation supported by the N.C. General Assembly. Its mission is to
provide long-term economic and societal benefits to North Carolina by
supporting biotechnology research, business and education statewide.


SOURCE North Carolina Biotechnology Center




Back to Topback to top

Related links:
  • http://www.ncbiotech.org
    CONTACT:
    Barry Teater, director of Corporate
    Communications of North Carolina Biotechnology Center,
    +1-919-541-9366, or barry_teater@ncbiotech.org